see more

Shinya Yamanaka, director of the Center for iPS Cell Research and Application (CiRA) and Nobel laureate, speaks during an interview at Takeda Pharmaceutical Co.'s Shonan Research Center in Fujisawa, Kanagawa Prefecture, Japan, on Tuesday, Dec. 15, 2015. Under a ten-year, $170 million pact, Takeda will partner with Yamanaka's center to study ways to use cell technologies for conditions such as diabetes and cancer. Photographer: Yuriko Nakao/Bloomberg via Getty Images

Shinya Yamanaka, director of the Center for iPS Cell Research and Application (CiRA) and Nobel laureate, speaks during an interview at Takeda Pharmaceutical Co.'s Shonan Research Center in Fujisawa, Kanagawa Prefecture, Japan, on Tuesday, Dec. 15, 2015. Under a ten-year, $170 million pact, Takeda will partner with Yamanaka's center to study ways to use cell technologies for conditions such as diabetes and cancer. Photographer: Yuriko Nakao/Bloomberg via Getty Images